The genetic test reveals specific variantssuch as FTO rs9939609that relate to GLP-1 signaling efficiency and metabolic response
E., Dohna-Schwake, C., Hanssler, L., Neudorf, U., Hoyer, P
A 2024 study evaluating real-world data reported similar findings, suggesting that the absolute risk of pancreatitis is minimal, especially compared to the overall benefits of GLP-1 therapies
Future research applications will likely expand to include investigation of senescence heterogeneity, tissue-specific senescent cell populations, and the development of personalized approaches to senolytic intervention based on individual senescent cell burden and characteristics